AG medicale, UAB - financials and debts

Company age: 16 y. 6 mo.

Update

AG medicale - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 126,068 129,699 126,278 113,756 136,525 103,671 93,345 128,347
Profit before tax 3,379 11,352 - - 11,698 -15,308 7,031 938
Net profit 2,868 9,496 -2,458 -479 9,943 -15,308 6,715 788
Equity -7,899 1,595 946 -1,334 -1,896 11,284 19,930 20,708
Liabilities 60,376 61,819 73,215 60,094 51,759 53,372 50,665 78,994
Non-current assets 5,075 4,202 3,320 10,258 9,375 2,238 1,065 674
Current assets 47,402 59,212 69,869 47,530 39,316 61,465 68,575 98,073
Total assets 52,477 63,414 73,189 57,788 48,691 63,703 69,640 98,747
Taxes paid
STI taxes - - - - - 21,366 21,808 23,075
Financial indicators
Revenue change y/y -23.0% +2.9% -2.6% -9.9% +20.0% -24.1% -10.0% +37.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 5.5% 15.0% -3.4% -0.8% 20.4% -24.0% 9.6% 0.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - 595.4% -259.8% - - -135.7% 33.7% 3.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 2.3% 7.3% -1.9% -0.4% 7.3% -14.8% 7.2% 0.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 2.7% 8.8% - - 8.6% -14.8% 7.5% 0.7%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 38.8 77.4 - - 4.7 2.5 3.8
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 126,068 129,699 126,278 113,756 71,229 65,478 93,345 77,007

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

AG medicale - Social security debts

From To Debt, €
2026-04-20 2026-04-23 244.97
2025-03-18 2025-03-25 47.74
2025-02-18 2025-03-17 16.92
2025-01-22 2025-02-16 16.91
2025-01-16 2025-01-21 16.80
2025-01-02 2025-01-05 19.79
2024-12-22 2024-12-31 19.79
2024-12-17 2024-12-20 19.79
2024-08-19 2024-08-20 17.56
2024-06-18 2024-06-27 16.95
2024-03-18 2024-03-21 21.41
2024-02-19 2024-03-17 0.80
2024-01-23 2024-02-18 0.50
2024-01-16 2024-01-22 0.26
2023-12-18 2024-01-09 23.73
2023-11-21 2023-12-17 0.95
2023-11-16 2023-11-20 23.45
2023-10-30 2023-11-15 0.67
2023-10-26 2023-10-29 0.47
2023-10-25 2023-10-25 0.67
2023-10-17 2023-10-24 0.47
2023-09-22 2023-10-11 0.19
2023-09-18 2023-09-21 22.69
2023-08-17 2023-08-20 106.37
2023-06-16 2023-07-12 1.32
2023-05-16 2023-06-13 1.02
2023-05-02 2023-05-11 0.76
2023-04-27 2023-04-28 0.76
2023-04-26 2023-04-26 0.55
2023-04-25 2023-04-25 0.76
2023-04-18 2023-04-24 0.55
2023-03-16 2023-04-16 0.25
2023-02-17 2023-02-23 87.72
2023-02-06 2023-02-16 0.53
2023-01-17 2023-02-03 0.53
2022-12-16 2023-01-15 0.53
2022-11-21 2022-12-12 0.53
2022-11-17 2022-11-18 0.53
2022-10-31 2022-11-13 0.53
2022-09-16 2022-09-21 86.89
2022-08-23 2022-08-29 83.70
2022-07-19 2022-08-22 0.02
2022-06-16 2022-07-12 0.02
2022-05-17 2022-06-02 0.02
2022-04-19 2022-04-27 0.02
2022-03-16 2022-04-13 0.02
2022-02-17 2022-03-13 0.01
2022-01-18 2022-02-13 0.01
2021-12-16 2022-01-11 0.01
2021-11-16 2021-12-09 0.01
2021-10-18 2021-11-14 0.01
2021-09-16 2021-10-11 0.01

AG medicale - VMI tax arrears

As of 2026-09-02, the amount of overdue STI tax debt of the company AG medicale is: 158 €

From To Overdue, €
2026-09-01 2026-09-02 158.18
2026-08-18 2026-08-31 157.2
2026-08-14 2026-08-17 156.55
2026-08-12 2026-08-13 168.76
2026-08-02 2026-08-11 156.55
2026-07-01 2026-08-01 155.31
2026-06-28 2026-06-30 154.4
2026-06-01 2026-06-05 4.4
2026-05-06 2026-05-31 1.41
2026-05-01 2026-05-05 1840.41
2026-04-30 2026-04-30 1826.0
2026-04-22 2026-04-23 998.09
2026-04-17 2026-04-21 2186.07
2026-04-14 2026-04-16 2382.5
2026-04-01 2026-04-13 2370.56
2026-03-29 2026-03-31 2364.0
2026-03-11 2026-03-12 11.94
2026-03-02 2026-03-10 1100.11
2026-02-18 2026-03-01 1.4
2026-02-03 2026-02-17 1076.92
2026-01-29 2026-02-02 1075.52
2025-11-14 2025-11-25 4.52
2025-11-09 2025-11-13 16.46
2025-11-08 2025-11-08 18.56
2025-11-06 2025-11-07 1620.89
2025-11-02 2025-11-05 1608.95
2025-10-30 2025-11-01 1843.1
2025-10-16 2025-10-29 2.1
2025-10-02 2025-10-15 1621.41
2025-09-28 2025-10-01 1617.22
2025-09-14 2025-09-27 2.22
2025-09-12 2025-09-13 14.16
2025-09-11 2025-09-11 729.76
2025-09-01 2025-09-10 717.82
2025-08-31 2025-08-31 715.6
2025-08-28 2025-08-30 1603.46
2025-08-14 2025-08-27 2.46
2025-08-08 2025-08-13 14.4
2025-08-02 2025-08-07 2.46
2025-07-28 2025-08-01 1535.0
2025-07-09 2025-07-20 2279.19
2025-07-01 2025-07-08 2534.84
2025-06-28 2025-06-30 2530.72
2025-06-21 2025-06-27 0.72
2025-06-19 2025-06-20 1352.0
2025-06-02 2025-06-18 8.28
2025-05-29 2025-05-30 1873.4
2025-05-24 2025-05-28 2.4
2025-05-17 2025-05-23 14.22
2025-05-07 2025-05-16 1781.08
2025-05-01 2025-05-06 1769.26
2025-04-28 2025-04-30 1765.0
2025-04-23 2025-04-23 2.88
2025-04-11 2025-04-22 14.61
2025-04-05 2025-04-10 2.88
2025-04-02 2025-04-04 1732.19
2025-03-28 2025-04-01 1765.27
2025-03-27 2025-03-27 3.27
2025-03-15 2025-03-26 15.0
2025-03-05 2025-03-14 3.27
2025-03-02 2025-03-04 4024.27
2025-02-28 2025-03-01 4021.0
2025-02-18 2025-02-18 7.17
2025-02-05 2025-02-17 18.9
2025-02-02 2025-02-04 7.17
2025-02-01 2025-02-01 2.76
2025-01-31 2025-01-31 27.76
2025-01-30 2025-01-30 409.16
2025-01-08 2025-01-29 384.16
2025-01-01 2025-01-07 2597.49
2024-12-30 2024-12-31 4387.02
2024-12-17 2024-12-29 1814.02
2024-12-04 2024-12-16 2303.4
2024-12-03 2024-12-03 2935.85
2024-11-28 2024-12-02 2932.69
2024-09-02 2024-11-27 6.9

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
AG medicale, UAB (code 302488544) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the latest financial year, revenue increased to €128.3K, up 37.5% year on year and 23.8% compared with 2023. Net profit was €788, which corresponded to a profit margin of 0.6%. This followed a much stronger 2024 result, when revenue declined to €93.3K but the company generated net profit of €6.7K after a loss of €15.3K in 2023. The three-year pattern shows a return to profitability in 2024 and a weaker margin in 2025 despite higher sales. At year-end 2025, total assets stood at €98.7K, supported by €20.7K of equity and €79.0K of liabilities. The equity ratio was 21.0%, debt-to-equity was 3.81, asset turnover was 1.30x, ROE was 3.8%, and ROA was 0.8%. Revenue per employee was €128.3K, with profit per employee of €788.